ConductScience.org, home

Paper40874151

Breaking the oncogenic alliance: advances in disrupting the MTDH-SND1 complex for cancer therapy.

Ahmed NA and 5 others. RSC Adv, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Breaking the oncogenic alliance: advances in disrupting the MTDH-SND1 complex for cancer therapy. Papers, record 40874151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40874151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Breaking the oncogenic alliance: advances in disrupting the MTDH-SND1 complex for cancer therapy.
PubMed
Journal
RSC Adv
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.48, provisional
iCite
Revised in PubMed
2025-09-15
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ahmed NANoha Ahttps://orcid.org/0000-0002-5080-0933
2Allam AAAhmed A
3Rudayni HAHassan A
4Aba Alkhayl FFFaris F
5Lamsabhi AMAl Mokhtarhttps://orcid.org/0000-0002-1509-2513
6Kamel EMEmadeldin M

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References133

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135121995Breaking up MTDH-SND1 to break down metastasis.Nat Cancer2022https://conductscience.org/library/papers/35121995PubMed
233809714Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments.Cells2021https://conductscience.org/library/papers/33809714PubMed
337693734Cheminformatics and biomolecular dynamics studies towards the discovery of anti-staphylococcal nuclease domain-containing 1 (SND1) inhibitors to treat metastatic breast cancer.Saudi Pharm J2023https://conductscience.org/library/papers/37693734PubMed
438758610Advancing Drug Safety in Drug Development: Bridging Computational Predictions for Enhanced Toxicity Prediction.Chem Res Toxicol2024https://conductscience.org/library/papers/38758610PubMed
536258022A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasis.Oncogene2023https://conductscience.org/library/papers/36258022PubMed
638107173Stabilized cyclic peptides as modulators of protein-protein interactions: promising strategies and biological evaluation.RSC Med Chem2023https://conductscience.org/library/papers/38107173PubMed
731649842Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins.Acta Pharm Sin B2019https://conductscience.org/library/papers/31649842PubMed
838062861Peptide drugs: a new direction in cancer immunotherapy.Cancer Biol Med2023https://conductscience.org/library/papers/38062861PubMed
931111296Nanoparticles: Oral Delivery for Protein and Peptide Drugs.AAPS PharmSciTech2019https://conductscience.org/library/papers/31111296PubMed
1023986882Tumor-penetrating peptides.Front Oncol2013https://conductscience.org/library/papers/23986882PubMed
1135939049Hotspot Identification and Drug Design of Protein-Protein Interaction Modulators Using the Fragment Molecular Orbital Method.J Chem Inf Model2022https://conductscience.org/library/papers/35939049PubMed
1231978555Molecular and cellular insights into the role of SND1 in lipid metabolism.Biochim Biophys Acta Mol Cell Biol Lipids2020https://conductscience.org/library/papers/31978555PubMed
1334195230Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives.Front Mol Biosci2021https://conductscience.org/library/papers/34195230PubMed
1421892917PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery.Curr Drug Metab2012https://conductscience.org/library/papers/21892917PubMed
1532692162Challenges and Opportunities in Cancer Drug Resistance.Chem Rev2021https://conductscience.org/library/papers/32692162PubMed
1622437869Combining immunotherapy and targeted therapies in cancer treatment.Nat Rev Cancer2012https://conductscience.org/library/papers/22437869PubMed
1732645525A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors.Genomics2020https://conductscience.org/library/papers/32645525PubMed
1825112216Cell penetration: scope and limitations by the application of cell-penetrating peptides.J Pept Sci2014https://conductscience.org/library/papers/25112216PubMed
1935609735MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy.Cancer Lett2022https://conductscience.org/library/papers/35609735PubMed
2035656714Structural landscapes of PPI interfaces.Brief Bioinform2022https://conductscience.org/library/papers/35656714PubMed

See all 133 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42883989Computational Investigation of S781F Mutation-Induced Remodeling of the Staphylococcal Nuclease Domain-Containing Protein 1-Argonaute 2 Interface.Int J Mol Sci2026https://conductscience.org/library/papers/42883989PubMed
42611115Oxygenated 9H-carbazole-3-carbaldehyde scaffolds as cerebral cavernous malformation-relevant protein-protein interaction disruptors of the HEG1-KRIT1 interface.J Comput Aided Mol Des2026https://conductscience.org/library/papers/42611115PubMed
422100061H-Indazole-3-Carboxylic Acid Derivatives as Disruptors of the Oncogenic MTDH-SND1 Protein-Protein Interaction: An In Silico-to-In Vitro Study.Cell Biochem Biophys2026https://conductscience.org/library/papers/42210006PubMed
41563710AEG-1/MTDH Enhances Hepatocellular Carcinoma Radioresistance by Recruiting PTBP1 Via SND1 To Stabilize ATG5 mRNA and Promote Protective Autophagy.Cell Biochem Biophys2026https://conductscience.org/library/papers/41563710PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
MTDH92140PubTator's text mininghttps://conductscience.org/library/genes/92140NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
PIK3CB5291PubTator's text mininghttps://conductscience.org/library/genes/5291NCBI Gene
SND127044PubTator's text mininghttps://conductscience.org/library/genes/27044NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40874151

GET https://conductscience.org/api/papers/v1/40874151/references?page=2